Axon Enterprise, Inc. (NASDAQ:AXON) Holdings Decreased by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 56.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,687 shares of the biotechnology company's stock after selling 2,192 shares during the period. Exchange Traded Concepts LLC's holdings in Axon Enterprise were worth $674,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Mather Group LLC. increased its holdings in Axon Enterprise by 3.7% in the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company's stock valued at $303,000 after purchasing an additional 27 shares in the last quarter. CWM LLC grew its stake in shares of Axon Enterprise by 1.3% in the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company's stock valued at $1,141,000 after buying an additional 36 shares in the last quarter. Dorsey Wright & Associates raised its holdings in shares of Axon Enterprise by 0.3% during the 2nd quarter. Dorsey Wright & Associates now owns 14,053 shares of the biotechnology company's stock valued at $4,135,000 after buying an additional 39 shares during the period. Avantax Advisory Services Inc. boosted its holdings in Axon Enterprise by 0.8% in the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company's stock worth $1,659,000 after acquiring an additional 40 shares during the period. Finally, Brookstone Capital Management boosted its holdings in Axon Enterprise by 5.1% in the 1st quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company's stock worth $263,000 after acquiring an additional 41 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insider Transactions at Axon Enterprise

In related news, CFO Brittany Bagley sold 4,338 shares of the business's stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the transaction, the chief financial officer now owns 98,825 shares in the company, valued at $37,449,733.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the sale, the chief financial officer now owns 98,825 shares of the company's stock, valued at $37,449,733.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of the business's stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares of the company's stock, valued at $1,121,052,771.48. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 371,172 shares of company stock worth $137,000,162. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 0.8 %

AXON stock opened at $438.05 on Friday. The firm has a market cap of $33.10 billion, a price-to-earnings ratio of 115.58, a PEG ratio of 11.74 and a beta of 0.94. Axon Enterprise, Inc. has a 1-year low of $199.29 and a 1-year high of $440.89. The firm has a fifty day moving average price of $388.71 and a two-hundred day moving average price of $331.64. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating analysts' consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the firm earned $0.80 EPS. The company's revenue for the quarter was up 34.5% compared to the same quarter last year. Research analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Jefferies Financial Group assumed coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They set a "buy" rating and a $385.00 target price on the stock. Northland Securities upped their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an "outperform" rating in a research report on Thursday, August 8th. Craig Hallum lifted their target price on Axon Enterprise from $370.00 to $376.00 and gave the stock a "buy" rating in a research report on Wednesday, August 7th. Barclays boosted their price target on Axon Enterprise from $381.00 to $387.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 7th. Finally, JMP Securities raised their price objective on Axon Enterprise from $375.00 to $430.00 and gave the company an "outperform" rating in a research note on Thursday, September 12th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $365.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.